Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries.

To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each containing a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site. These compounds were synthesized by using click chemistry. Screening identified HDAC8-selective inhibitors including C149 (IC(50) = 0.070 μM), which was more potent than PCI-34058 (6) (IC(50) = 0.31 μM), a known HDAC8 inhibitor. Molecular modeling suggested that the phenylthiomethyl group of C149 binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity. The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI(50) = 3-80 μM). These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.

[1]  D. Christianson,et al.  Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases. , 2011, Journal of the American Chemical Society.

[2]  M. Varasi,et al.  Nicotinoyl azide (NCA)-mediated Mitsunobu reaction: An expedient one-pot transformation of alcohols into azides , 2004 .

[3]  S. Matsuoka,et al.  Synthesis and biological evaluation of triazole analogues of antillatoxin , 2011 .

[4]  Karunakaran A Kalesh,et al.  High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. , 2009, Organic letters.

[5]  S. Oh,et al.  An efficient F-18 labeling method for PET study: Huisgen 1,3-dipolar cycloaddition of bioactive substances and F-18-labeled compounds , 2007 .

[6]  T. Suzuki,et al.  Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. , 1999, Journal of medicinal chemistry.

[7]  Michelle R. Arkin,et al.  Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.

[8]  V. Fokin,et al.  Cu‐Catalyzed Azide‐Alkyne Cycloaddition: Preparation of Tris((1‐Benzyl‐1H‐1,2,3‐Triazolyl)Methyl)Amine , 2012 .

[9]  V. Castronovo,et al.  Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. , 2004, The American journal of pathology.

[10]  T. Nakano,et al.  Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors. , 2009, Journal of medicinal chemistry.

[11]  Karunakaran A Kalesh,et al.  Methods of using click chemistry in the discovery of enzyme inhibitors , 2007, Nature Protocols.

[12]  G. Zanardi,et al.  Reaction of Azides with Dichloroindium Hydride: Very Mild Production of Amines and Pyrrolidin-2-imines Through Possible Indium—Aminyl Radicals. , 2006 .

[13]  R. De Francesco,et al.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Atadja,et al.  Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. , 2011, Bioorganic & medicinal chemistry.

[15]  Michele Pallaoro,et al.  HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics , 2007, Cell Research.

[16]  Yukihiro Itoh,et al.  Isoform-selective histone deacetylase inhibitors. , 2008, Current pharmaceutical design.

[17]  Eric Verdin,et al.  Histone deacetylase HDAC8 associates with smooth muscle α‐actin and is essential for smooth muscle cell contractility , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Binaschi,et al.  Histone deacetylase inhibitors: from bench to clinic. , 2008, Journal of medicinal chemistry.

[19]  M. Navre,et al.  Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. , 2010, Bioorganic & medicinal chemistry letters.

[20]  Morten Meldal,et al.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.

[21]  P. Marks,et al.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Karamouzis,et al.  Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond , 2007, Expert opinion on investigational drugs.

[23]  R A Rifkind,et al.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Schreiber,et al.  Discovery of Histone Deacetylase 8 Selective Inhibitors. , 2012 .

[25]  Minoru Yoshida,et al.  Protein deacetylases: enzymes with functional diversity as novel therapeutic targets. , 2003, Progress in cell cycle research.

[26]  P. Wang,et al.  Histone deacetylase inhibitors through click chemistry. , 2008, Journal of medicinal chemistry.

[27]  Takayoshi Suzuki,et al.  Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates. , 2005, Journal of medicinal chemistry.

[28]  Silvio Massa,et al.  Histone deacetylation in epigenetics: An attractive target for anticancer therapy , 2005, Medicinal research reviews.

[29]  M. Uttamchandani,et al.  Rapid assembly of matrix metalloprotease inhibitors using click chemistry. , 2006, Organic letters.

[30]  Thomas A. Miller,et al.  Histone deacetylase inhibitors. , 2003, Journal of medicinal chemistry.

[31]  A. Oyelere,et al.  Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. , 2008, Bioorganic & medicinal chemistry.

[32]  M. Jung,et al.  Chromatin Modifications as Targets for New Anticancer Drugs , 2005, Archiv der Pharmazie.

[33]  J. R. Somoza,et al.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. , 2004, Structure.

[34]  Guoxian Gu,et al.  Structure-based optimization of click-based histone deacetylase inhibitors. , 2011, European journal of medicinal chemistry.

[35]  J. Buggy,et al.  Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation , 2008, Leukemia.

[36]  Barbara Hero,et al.  Histone Deacetylase 8 in Neuroblastoma Tumorigenesis , 2009, Clinical Cancer Research.

[37]  Y. Oda,et al.  Expression profile of class I histone deacetylases in human cancer tissues. , 2007, Oncology reports.

[38]  C. Fierke,et al.  Structures of metal-substituted human histone deacetylase 8 provide mechanistic inferences on biological function . , 2010, Biochemistry.

[39]  Chi‐Huey Wong,et al.  A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry , 2003 .

[40]  Ricardo Macarron,et al.  Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  S. Horinouchi,et al.  Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  Yukihiro Itoh,et al.  Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. , 2007, Journal of medicinal chemistry.

[43]  R. De Francesco,et al.  Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex , 2007, EMBO reports.

[44]  T. Kummalue,et al.  The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain , 2003, Molecular and Cellular Biology.

[45]  C. Fierke,et al.  Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. , 2008, Biochemistry.

[46]  Yukihiro Itoh,et al.  Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. , 2006, Journal of medicinal chemistry.

[47]  Stuart L Schreiber,et al.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. , 2002, Chemistry & biology.

[48]  Luke G Green,et al.  A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.

[49]  J. Clark,et al.  Cloning and characterization of a novel human histone deacetylase, HDAC8. , 2000, The Biochemical journal.

[50]  Mahesh Uttamchandani,et al.  Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases. , 2006, Organic letters.

[51]  Takayoshi Suzuki,et al.  An unexpected example of protein-templated click chemistry. , 2010, Angewandte Chemie.

[52]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[53]  Takayoshi Suzuki,et al.  Epigenetic control using natural products and synthetic molecules. , 2006, Current medicinal chemistry.

[54]  M. G. Finn,et al.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions , 2001 .

[55]  Eric Verdin,et al.  Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[56]  A. Giannis,et al.  Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes. , 2005, Angewandte Chemie.

[57]  James D. Winkler,et al.  Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor* , 2000, The Journal of Biological Chemistry.

[58]  Giuseppe Bifulco,et al.  A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. , 2010, Journal of medicinal chemistry.

[59]  Gabriele Gillessen-Kaesbach,et al.  HDAC8 mutations in Cornelia de Lange Syndrome affect the cohesin acetylation cycle , 2012, Nature.

[60]  Minoru Yoshida,et al.  [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. , 1990, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.